Supplier News Breaks Archives
John Sullivan has been named vice president of sales at Kao USA.
Forest Laboratories Inc. has rolled out Fetzima extended-release capsules, a medication for major depressive disorder (MDD), to U.S. pharmacies.
In the wake of its recent success of the thought-provoking "Be Strong and Shine" viral video, which depicts gender labels in the workplace, Pantene is launching the global #ShineStrong campaign.
Bristol-Myers Squibb Co. has agreed to sell its global diabetes business that was part of its collaboration with AstraZeneca.
GlaxoSmithKline plc and Theravance Inc. have received Food and Drug Administration approval for Anoro Ellipta as a combination anticholinergic/long-acting beta2-adrenergic agonist (LABA) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
SheaMoisture has won accolades, including "best of beauty" and similar awards, from a variety high-profile publications during 2013.
Perrigo Co. has completed its $8.6 billion deal to acquire Irish pharmaceutical company Elan Corp.
Pfizer Inc. and Teva Pharmaceutical Industries Ltd. have reached a settlement to resolve patent litigation related to Teva's generic version of Pfizer's Viagra erectile dysfunction tablets.
Depomed Inc. has acquired the United States rights to migraine medication Cambia (diclofenac potassium for oral solution) from Nautilus Neurosciences for $48.7 million.
Boca Cosmetics Group's Zelo Brazilian Keratin hair care line is now being sold through Walgreens.com.
Pfizer Inc. has named company veteran Albert Bourla as group president of its Vaccines, Oncology and Consumer Healthcare business.
The Food and Drug Administration has proposed a rule calling on manufacturers of antibacterial hand soaps and body washes to show that their products are safe for long-term daily use and more effective than plain soap and water in preventing illness and the spread of certain infections.
Kellogg Co. is introducing a flurry of new products from some of its most popular brands, including cereal, snacks and frozen foods.
Endo Health Solutions plans to acquire specialty drug maker NuPathe Inc. in a $105 million cash deal.